Another methylation panel of six genes (SOX17, HOXA9, AJAP1, PTGDR, UNCX, MARCH11) was evaluated in tumor and adjacent normal lung tissue from 90 NSCLC patients showing a high sensitivity (96.7%) and specificity (60%) [20]. This evidence concerns the gene HOXA9 and non-small cell lung carcinoma.